title: Insufficient outcomes with imatinib mesylate: case report of Ph-positive acute myeloid leukemia evolving from myelodysplastic syndrome.
authors.forename: Atsushi
authors.initials: A
authors.lastname: Isoda
authors.forename: Hirotaka
authors.initials: H
authors.lastname: Nakahashi
authors.forename: Takumi
authors.initials: T
authors.lastname: Hoshino
authors.forename: Takeki
authors.initials: T
authors.lastname: Mitsui
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Yoshida
mesh_terms: D000208:Acute Disease; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001549:Benzamides; D007446:Chromosome Inversion; D002893:Chromosomes, Human, Pair 3 / Q000235:genetics; D020732:Cytogenetic Analysis; D018450:Disease Progression; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D017404:In Situ Hybridization, Fluorescence; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics; D010879:Piperazines / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*; D012008:Recurrence; D017211:Treatment Failure
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate